Showing 37–45 of 65 results
The MTRR A66G test is a genetic screening tool that identifies a specific variant (A66G) in the MTRR gene, which plays a crucial role in folate metabolism and homocysteine regulation. Key features include accurate DNA analysis, easy sample collection (typically via saliva or cheek swab), and fast turnaround time.
NGS Cancer Gene Panel – Custom 4-Gene Marker Testing for Precision Oncology Introducing the NGS Cancer Gene Panel – Any Four Markers/Genes: a powerful, customizable solution for precision oncology and advanced cancer diagnostics. This targeted next-generation sequencing (NGS) panel allows you to select any four cancer-related genes or biomarkers, enabling focused, high-resolution analysis tailored to your specific research or diagnostic needs. Features: – Customizable Gene Selection: Choose any four genes from a comprehensive list of clinically relevant cancer markers, including but not limited to TP53, BRCA1/2, EGFR, KRAS, BRAF, ALK, and PIK3CA. This flexibility ensures that your panel is aligned with the cancer type or pathway of interest. – High Sensitivity and Specificity: Utilizing cutting-edge NGS technology, this panel delivers accurate detection of single nucleotide variants (SNVs), insertions/deletions (indels), copy number variations (CNVs), and gene fusions, even at low allele frequencies. – Streamlined Workflow: Optimized for rapid turnaround, the panel integrates seamlessly into existing laboratory pipelines, with minimal hands-on time and efficient data analysis supported by robust bioinformatics tools. – Clinical Relevance: Each gene included in the panel is backed by extensive literature and clinical evidence, supporting its role in cancer pathogenesis, prognosis, or therapeutic response. This ensures that your results are not only accurate but also actionable. – Sample Versatility: Compatible with a wide range of sample types, including FFPE tissue, blood (cfDNA), and fresh frozen specimens, making it ideal for both retrospective studies and real-time diagnostics. Benefits: – Personalized Insights: Gain deep molecular insights into tumor biology, enabling personalized treatment strategies and improved patient outcomes. – Cost-Effective Precision: Focused testing on four key genes reduces costs while maintaining high diagnostic value, making it ideal for targeted research or clinical applications. – Accelerated Decision-Making: Fast and reliable results support timely clinical decisions, particularly in cases where rapid therapeutic intervention is critical. – Regulatory-Ready Data: Designed to meet stringent quality standards, the panel supports compliance with clinical laboratory regulations and guidelines. Test Overview Test Name: NGS Cancer Gene – Any Four Marker Gene Sample Type: Blood or Tissue (as required) Method: Next-Generation Sequencing (NGS) Panel Size: Custom selection of four marker genes relevant to the patient’s cancer type Why Choose This Test? Personalized Treatment Planning: Helps identify targeted therapies or clinical trials tailored to your genetic profile. Early Detection & Prognosis: Assists in early diagnosis and provides prognostic information for better disease management. High Sensitivity & Accuracy: Utilizes state-of-the-art sequencing technology for reliable results. Customizable: Select any four genes from a list of clinically significant cancer markers based on your doctor’s recommendation. Commonly Tested Cancer Genes Include: BRCA1 / BRCA2 (Breast, Ovarian, Prostate cancers) EGFR (Lung cancer) KRAS / NRAS (Colorectal, Lung, Pancreatic cancers) TP53 (Various cancers including Li-Fraumeni syndrome) ALK , ROS1 , BRAF , HER2 , and others as needed Who Should Consider This Test? Patients diagnosed with cancer seeking targeted therapy options. Individuals with a family history of hereditary cancers. Oncologists looking to guide treatment decisions using molecular profiling. How It Works Consultation: Speak with your doctor or specialist about whether genetic testing is suitable for you. Order the Test: Dubai Lab Tests will coordinate sample collection at your convenience. Receive Results: Comprehensive reports are delivered to your physician to help guide your treatment plan. The NGS Cancer Gene Panel – Any Four Markers/Genes empowers you with a tailored, high-performance tool for cancer genomics. Whether you’re investigating tumor mutations, monitoring disease progression, or guiding targeted therapy, this panel delivers the precision, flexibility, and reliability you need. Unlock the potential of personalized oncology with a solution that adapts to your unique diagnostic and research goals. At Dubai Lab Tests, we are committed to delivering high-quality diagnostic services with a focus on innovation and patient care. Our NGS Cancer Gene panel ensures you get the most precise and actionable insights into your cancer genetics.
NutriFit is a comprehensive DNA test that analyzes genetic predispositions related to nutrition, metabolism, and fitness. It provides personalized insights into nutrient absorption, food intolerances, metabolic efficiency, and optimal diet types. The test also evaluates genetic factors influencing weight management, muscle performance, and recovery, helping users tailor their diet and exercise plans for maximum effectiveness.
The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.